NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.
NovaSignal has raised $37.0M in total funding. The most recent round was Series C. The last funding was announced in September 2021.
NovaSignal's investors include Alpha Edison, National Science Foundation, National Institutes of Health, MassChallenge, TCA Venture Group.
NovaSignal is headquartered in Los Angeles, United States.
NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.
NovaSignal is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NovaSignal — Funding & Investors." VCBacked, September 28, 2021, https://www.vcbacked.co/company/novasignal. Accessed November 12, 2026.
VCBacked. (2021). NovaSignal — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/novasignal
{{cite web |title=NovaSignal — Funding & Investors |url=https://www.vcbacked.co/company/novasignal |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at NovaSignal? Request a listing update